06.10.2025, 19:00 - 21:00 GMT
Seminar
Come meet a united coalition from Norway’s healthcare system and healthcare industry to discuss Norway’s ambitious strategic plan aimed at strengthening Norway’s position as a leading country of excellence in the field of clinical trials.
The Norwegian Ministry of health has launched an ambitious strategic plan to strengthen Norway as a country of excellence for clinical trials. In collaboration with the industry, NorTrials as a national entry point for global companies wishing to conduct clinical trials in Norway, was established in 2022.
A well-structured specialist care system and a population with a high willingness to partake in clinical trialsRepresentatives from the Embassy, the healthcare industry, key-opinion leaders from the clinical side, Innovation Norway and NorTrials will meet and discuss how choosing Norway as a preferred clinical trials hosting country will strengthen the pipeline execution and advance strategic clinical trial development.
We invite you to join us and hear from our experts as they present the clinical trials strategy of the future.
Signe Øien Fretland
Head of NorTrials coordinating unit; Cand. Pharm.
Maria C. Lundstad Aulie
Investment Manager | Greater Oslo region
Health and life science
Jannik Grodt Schmidt
Investment Manager | USA
Health and life science